<div id="readability-page-1"><div>         <div>                        <p>,  /PRNewswire/ -- <u>CoreAge Rx</u>, a leading telehealth pharmacy specializing in personalized medication services, today announced a strategic New Year's expansion of its compounded <span>GLP-1</span> weight management program. The expansion provides increased access to compounded tirzepatide and semaglutide, perfectly timed to support Americans pursuing their 2026 health and wellness resolutions.</p>             <p><span>                 Continue Reading                   <br/>                   <i></i>                                </span>             </p>             <div>               <div>                 <div>                                       <div>                                                               <figure>                        <p><img id="imageid_2" src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://www.prnewswire.com/news-releases/null"/>                    </p>                       <figcaption>         CoreAge Rx (PRNewsfoto/CoreAge Rx)       </figcaption>     </figure>                                                                                  </div>                 </div>               </div>             </div>             <p>As millions of Americans set ambitious weight loss goals for the new year, CoreAge Rx's expansion addresses surging demand for accessible, affordable <span>GLP-1</span> medications. Many patients face barriers including cost, insurance limitations, and ongoing supply shortages of brand-name medications.</p>                            <p>&#34;The start of a new year represents a powerful moment for change, and we're seeing unprecedented interest in medically supported weight management solutions,&#34; said Ella Jones, spokesperson for CoreAge Rx. &#34;Our expansion is designed to meet patients where they are—ready to commit to their health goals but facing significant access barriers. We're ensuring that 2026 is the year when effective weight management becomes truly accessible.&#34;</p>               <p>CoreAge Rx's timing is strategic. Research shows January marks the peak period for health-related goal setting, with weight loss ranking among top New Year's resolutions. However, many individuals struggle to maintain momentum due to challenges in accessing affordable treatment options. CoreAge Rx's compounded <span>GLP-1</span> medications—prepared by licensed pharmacy partners to rigorous regulatory standards—provide an alternative pathway combining medical efficacy with practical accessibility.</p><p>The company's comprehensive telehealth model allows patients to complete consultations, receive prescriptions, and manage ongoing treatment entirely online. This approach eliminates traditional barriers for individuals balancing demanding schedules, family responsibilities, and limited access to specialized in-person providers.</p><p>As part of the New Year's expansion, <u>CoreAge Rx</u> is enhancing its digital platform, strengthening patient education resources, and optimizing fulfillment processes to ensure consistent medication availability during peak demand. The company remains committed to competitive pricing and flexible shipping options.</p><p>&#34;We're celebrating our patients' commitment to themselves,&#34; Jones added. &#34;Our expansion ensures we're ready to support every individual who's decided that 2026 is their year for meaningful, sustainable change.&#34;</p><p>For more information about CoreAge Rx's compounded <span>GLP-1</span> programs or to begin your 2026 wellness journey, visit <u>https://www.coreagerx.com/</u>.</p><p>SOURCE CoreAge Rx</p><p><img src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIwJk5ld3NJdGVtSWQ9Tlk2NzM2MSZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjAxNzUyUFJfTkVXU19VU1BSX19fX19OWTY3MzYx?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://rt.prnewswire.com/rt.gif/query-RGF0ZUlkPTIwMjYwMTIwJk5ld3NJdGVtSWQ9Tlk2NzM2MSZUcmFuc21pc3Npb25fSWQ9MjAyNjAxMjAxNzUyUFJfTkVXU19VU1BSX19fX19OWTY3MzYx"/></p></div>       </div></div>

<p>CoreAge Rx, a telehealth pharmacy, has announced an expansion of its compounded GLP-1 weight management program to support New Year's weight loss goals. This initiative aims to increase access to medications like tirzepatide and semaglutide, addressing barriers such as cost and supply shortages. The expansion includes enhancements to their digital platform and patient education resources, ensuring consistent medication availability. CoreAge Rx's telehealth model allows patients to manage their treatment online, making effective weight management more accessible as many Americans set health resolutions for 2026.</p>

prnewswire

Direxion Daily LLY Bull 2X Shares

Defiance Daily Target 2X Long LLY ETF

Invesco Biotechnology & Genome ETF

Defiance Daily Target 2X Long NVO ETF

VanEck Biotech ETF

Health Care Select Sector SPDR

iShares Global Healthcare

ALPS Medical Breakthrough

Invesco Nasdaq Biotechnology ETF

Novo Nordisk AS

Proshares Ultra Nasdaq Biotech

Eli Lilly

First Trust NYSE Arca Biotech Index Fd

iShares US Medical Devices

SPDR S&P Biotech

VG Health

iShares Biotechnology ETF

SPDR S&P Health Equip

iShares US Pharma

17:52 ET
			
			
				CoreAge Rx Expands GLP-1 Access to Support New Year Weight Loss Goals

17:52 ET CoreAge Rx Expands GLP-1 Access to Support New Year Weight Loss Goals